The most infectious prion protein particles

Nature

Volumn 437, Issue 7056, 2005, Pages 257-261

  Silveira, Jay R ^a   Raymond, Gregory J ^a   Hughson, Andrew G ^a   Race, Richard E ^a   Sim, Valerie L ^a   Hayes, Stanley F ^a   Caughey, Byron ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; ELECTROPHORESIS; FIBERS; LIGHT SCATTERING; NEUROLOGY; OLIGOMERS;

AMYLOID FIBRILS; ENIGMATIC AGENT; GEL ELECTROPHORESIS; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSE);

PROTEINS;

OLIGOMER; PRION PROTEIN;

MEDICINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FRACTIONATION; GEL ELECTROPHORESIS; INFECTION; LIGHT SCATTERING; MOLECULAR WEIGHT; MOLECULE; NONHUMAN; PARTICLE SIZE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; ANIMAL; BRAIN; CHEMISTRY; DISEASE TRANSMISSION; HAMSTER; IMMUNOBLOTTING; ISOLATION AND PURIFICATION; METABOLISM; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN QUATERNARY STRUCTURE; RADIATION SCATTERING; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; BRAIN; CHEMICAL FRACTIONATION; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOBLOTTING; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR WEIGHT; PRION DISEASES; PROTEIN STRUCTURE, QUATERNARY; PRPSC PROTEINS; SCATTERING, RADIATION;

EID: 24644448839     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03989     Document Type: Article

References (27)

1. Caughey, B. & Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267-298 (2003).
2. Kayed, R. et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366 (2004).
3. Kocisko, D. A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994).
4. Prusiner, S. B. Prions. Proc. Natl Acad Sci. USA 95, 13363-13383 (1998).
5. Silveira, J. R., Caughey, B. & Baron, G. S. Prion protein and the molecular features of transmissible spongiform encephalopathy agents. Curr. Top. Microbiol. Immunol. 284, 1-50 (2004).
6. Caughey, B., Raymond, G. J., Kocisko, D. A. & Lansbury, P. T. Jr Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J. Virol. 71, 4107-4110 (1997).
7. Prusiner, S. B. Molecular biology of prion diseases. Science 252, 1515-1522 (1991).
8. Brown, P., Liberski, P. P., Wolff, A. & Gajdusek, D. C. Conservation of infectivity in purified fibrillary extracts of scrapie-infected hamster brain after sequential enzymatic digestion or polyacrylamide gel electrophoresis. Proc. Natl Acad. Sci. USA 87, 7240-7244 (1990).
9. Safar, J. et al. Molecular mass, biochemical composition, and physicochemical behaviour of the infectious form of the scrapie precursor protein monomer. Proc. Natl Acad. Sci. USA 87, 6373-6377 (1990).
10. Hope, J. The nature of the scrapie agent: the evolution of the virino. Ann. NY Acad. Sci. 724, 282-289 (1994).
11. Morillas, M., Vanik, D. L. & Surewicz, W. K. On the mechanism of α-helix to β-sheet transition in the recombinant prion protein. Biochemistry 40, 6982-6987 (2001).
12. Alper, T., Haig, D. A. & Clarke, M. C. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 22, 278-284 (1966).
13. Gibbs, C. J. Jr, Gajdusek, D. C. & Latarjet, R. Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. Proc. Natl Acad. Sci. USA 75, 6268-6270 (1978).
14. Bellinger-Kawahara, C. G., Kempner, E., Groth, D., Gabizon, R. & Prusiner, S. B. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology 164, 537-541 (1988).
15. Gabizon, R., McKinley, M. P. & Prusiner, S. B. Purified prion proteins and scrapie infectivity copartition into liposomes. Proc. Natl Acad. Sci. USA 84, 4017-4021 (1987).
16. Raymond, G. J. et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388, 285-288 (1997).
17. Prusiner, S. B. et al. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19, 4883-4891 (1980).
18. Gast, K., et al. in Laser Light Scattering in Biochemistry (eds Harding, S. E., Sattelle, D. B. & Bloomfield, V. A.) 209-224 (The Royal Society of Chemistry, Cambridge, 1992).
19. Masel, J., Jansen, V. A. & Nowak, M. A. Quantifying the kinetic parameters of prion replication. Biophys. Chem. 77, 139-152 (1999).
20. Sc oligomer. J. Mol. Biol. 345, 1243-1251 (2005).
21. Tzaban, S. et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41, 12868-12875 (2002).
22. Riesner, D. et al. Disruption of prion rods generates 10-nm spherical particles having high α-helical content and lacking scrapie infectivity. J. Virol. 70, 1714-1722 (1996).
23. Jeffrey, M. et al. Correlative light and electron microscopy studies of PrP localisation in 87V scrapie. Brain Res. 656, 329-343 (1994).
24. Raymond, G. J. & Chabry, J. in Techniques in Prion Research (eds Lehmann, S. & Grassi, J.) 16-26 (Birkhauser, Basel, 2004).
25. Wahlund, K.-G. in Field-Flow Fractionation Handbook (eds Schimpf, M., Caldwell, K. & Giddings, J. C.) 279-294 (John Wiley & Sons, New York, 2000).
26. Kocisko, D. A. et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol. 77, 10288-10294 (2003).
27. Maxson, L., Wong, C., Herrmann, L. M., Caughey, B. & Baron, G. S. A solid-phase assay for identification of modulators of prion protein interactions. Anal. Biochem. 323, 54-64 (2003).